1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with phenidone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardaillou, R; Bens, M; Guidet, B; Lacave, R; Nagamine, Y; Rondeau, E; Sraer, J; Sraer, JD | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and phenidone
| Article | Year |
|---|---|
Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 5,8,11,14-Eicosatetraynoic Acid; Animals; Cell Line; Enzyme Precursors; Fatty Acids, Unsaturated; Isoquinolines; Kinetics; Masoprocol; Piperazines; Plasminogen Activators; Plasminogen Inactivators; Protein Kinase C; Pyrazoles; Tetradecanoylphorbol Acetate; Urokinase-Type Plasminogen Activator | 1990 |